followed by the conversion of PGG 2 to prostaglandin H 2 Information suggests that the cyclooxygenase (COX) (PGH 2 ) were identified as cyclooxygenase-1 (COX-1) and metabolites, the prostanoids, play a role in gall bladder COX-2 [prostaglandin endoperoxidase synthase, PGH synthase physiology and disease. Non-steroidal anti-inflammatory (8) ]. COX-1 is usually found to be a constitutive enzyme drugs which inhibit COX enzymes have been shown in vivo associated with unstimulated prostanoid formation, and and in vitro to alter the growth patterns of intestinal COX-2 is frequently inducible and produces prostanoids in epithelial cells, and specific COX-2 inhibitors have been response to various inflammatory and mitogenic stimuli (9, 10) . shown to decrease mitogenesis in intestinal epithelial cells.
We have shown in normal, freshly isolated human gall bladder The present study was intended to evaluate the effect of mucosal cells and cells from a human gall bladder cancer specific COX inhibitors on the growth patterns of gall cell line, that COX-2 is induced by the inflammatory agent bladder cancer cells. Employing a human gall bladder lysophosphatidylcholine and cytokines and that prostanoid cancer cell line, mitogenesis, apoptosis and prostaglandin formation in stimulated cells is primarily through a COX-2 E 2 (PGE 2 ) formation were evaluated in response to serum metabolic pathway (11) . and hepatocyte growth factor and transforming growth
Prostanoids have been of interest in cancer for many years factor α stimulation in the presence and absence of specific following the demonstration of high levels of prostanoids in COX-1 and -2 inhibitors. The effect of the mitogens on various tumors (12) . Additionally, various prostanoids were COX enzyme expression was also evaluated. Serum and shown to abrogate the growth of tumors in vivo and in various the growth factors increased COX enzyme expression and cancer cell lines (13) (14) (15) . The possible role of the COX mitogenesis, and decreased apoptosis as evaluated by the enzymes and prostanoids in carcinogenesis has been dramaticpercentage of cells that were floating in culture media ally emphasized by the accumulating evidence indicating that rather than attached. There was more DNA degradation NSAIDs decrease the number of colonic polyps in humans in floating than in attached cells. The specific COX-2 with adenomatous polyposis (16) and can reduce the incidence inhibitor, but not the COX-1 inhibitor, decreased mitoof colorectal cancers in experimental animals and humans (17) . genesis and increased gall bladder cell apoptosis as evaluGall bladder cancer and colon cancer have several analogous ated by the number of floating versus attached cells and characteristics. Colon cancer has an important association with the number of floating cells in the terminal phase of inflammatory bowel disease (18) and gall bladder cancer apoptosis or dead. The inhibition of mitogenesis and the primarily occurs in diseased gall bladders containing stones increased apoptosis produced by the COX-2 inhibitor was (19) . Both colon cancer and gall bladder cancer appear to associated with decreased PGE 2 production. The inhibition originate in polypoid disease in most patients (16, 20) . Recent of replication of gall bladder cancer cells and the increase information has indicated that COX enzymes are present in in apoptosis produced by the selective COX-2 inhibitor gall bladder cancer cells (11) and others have demonstrated suggests that the COX enzymes and the prostanoids may increased COX enzymes in human gall bladder cancer (21) . play a role in the development of gall bladder cancer and
The purpose of the present study was to evaluate the that the COX-2 inhibitors may have a therapeutic role in potential role of COX enzymes in the growth of a gall bladder the prevention of gall bladder neoplasms.
cancer cell line. It was intended to determine factors associated with the growth of gall bladder cancer cells and to ascertain if the growth pattern was altered by specific COX-1 and -2 Introduction inhibitors. Arachidonic acid metabolites play a significant role in gall bladder physiology and disease. The prostanoids have been Materials and methods shown to be involved in gall bladder muscle contraction, mucosal water transport and mucous secretion (1-3). ProCells from a well-differentiated gall bladder mucosal carcinoma were employed for these studies. The origination, characterization and maintenance of this stanoids have been shown to mediate gall bladder inflammatory cell line has been described previously (11) . For the experiments freshly thawed cells were cultured in Dulbecco's modified high glucose media supplemented with 100 000 IU/l penicillin, 100 000 IU/l streptomycin sulfate Abbreviations: BrdU, bromodeoxyuridine; COX, cyclooxygenase; FBS, fetal bovine serum; HGF, hepatocyte growth factor; NSAIDs, non-steroidal antiand 100 µg/l Na pyruvate (all from Sigma, St Louis, MO). The cells were cultured on collagen-coated culture dishes (Costar, Cambridge, MA) at a inflammatory drugs; PGE 2 , prostaglandin E 2 ; TGFα, transforming growth factor α; VSA, valerylsalicylic acid. density of 1ϫ10 6 cells/well and allowed to grow to confluence (~3 days), subcultured three times and the fourth passage employed for the experiments. The cells were morphologically homogenous and uniformly stained positive b COX-2 inhibitor, SC 58125, significantly altered the value produced by The concentrations of inhibitors used were based on previous dose-response serum or serum and growth factor. studies using these agents in intestinal epithelial cell experiments (25,26). After 24 h of exposure the cells were washed with PBS and treated with the same type media and agents, including 1.5 µCi/well [ 3 H]thymidine (ICN, precipitate was washed twice with 95% ethanol and DNA was dissolved in Costa Mesa, CA) for 7 h. The cells were then lysed with 100 µl of 0.1 M Tris-EDTA buffer, pH 8.0. DNA (10 µg) was pipetted onto a 1.8% agarose NaOH and 0.2% triton X-100 (Sigma) and the lysates precipitated with 20% gel and electrophoresis was performed. Following electrophoresis the gels trichloroacetic acid (TCA; Sigma). The precipitates were harvested in 5%
were stained for 1 h in Tris-borate-EDTA buffer containing SYBR ® Gold TCA onto 240-1 glass-fiber filters (Cambridge, Watertown, MA). The amount Nucleic Acid Gel Stain (Molecular Probes, Eugene, OR). of isotope incorporated into DNA was determined by liquid scintillation It was intended to ascertain if the mitogenic response produced was counting using a Beckman LS 100 instrument.
associated with induction of COX-1 or -2 enzyme formation. For western To confirm the results of the above experiments the study was repeated blotting of COX protein, 1ϫ10 6 cells were plated onto 12-well culture plates employing bromodeoxyuridine (BrdU) incorporation into DNA to estimate (Costar) in 1 ml DMEM. At 70% confluence, 10% FBS, 20 ng/ml HGF or replication (27) . Using the Biotrak cell proliferation ELISA assay system 20 ng/ml TGFα was added to the appropriate wells and the cells incubated (Amersham, Arlington Heights, IL) the above-described experimental protocol for 8 h. The attached cells were washed twice with PBS and the cells detached was repeated. BrdU (0.1 µg/ml) was added to the cells and incubated for 7 h.
with trypsin-EDTA and collected by centrifugation. The cell pellets were The culture medium was removed and the cells fixed with the DNA denatured lysed as described previously (11) . Protein concentration was determined by by adding the fixative. The peroxidase-labeled BrdU antibody was added and the method of Bradford (33) and 15 µg cytosolic protein was separated per the immune complexes detected by reading at 450 nm in a microtiter plate experimental condition by SDS-PAGE (11) . COX enzymes were identified spectrophotometer. The absorbance values correlate directly with the amount using antibodies and standard protein obtained from Oxford Biomedical of DNA synthesis and thereby to the number of proliferating cells in culture.
(Oxford, MI) (11). The effect of COX inhibitors on apoptosis was also evaluated. It has been
The effect of the mitogenic stimuli and the COX inhibitors on COX activity demonstrated by DNA laddering and cell morphology that the majority of was determined by quantifying prostaglandin E 2 (PGE 2 ) formation. The cells cells grown on culture plates floating in the media are apoptotic (28) (29) (30) .
were plated at a density of 1ϫ10 5 cells/well on collagen-coated culture dishes Apoptosis was quantitated by counting the number of floating cells and (Costar). Cells were treated with and without serum and serum-treated cells attached cells. Gall bladder cancer cells were plated at a density of 5ϫ10 6 were treated with HGF and TGFα with and without the COX inhibitors for cells/well. The cells were maintained with and without serum; serum-4 h. Following incubation the cells and media were separated and the media supplemented cells were treated with and without TGFα; and TGFα-treated centrifuged to remove any cells and then the media was frozen at -70°C. The cells were treated with and without SC 58125 for 96 h. The cells were washed cells were washed with PBS solution and 1 ml collagenase solution (Sigma) twice with PBS to obtain the floating cells and the attached cells were obtained was added to each well and incubated for 20 min. The cells were scraped with trypsin-EDTA treatment; attached and floating cell numbers were from the wells, centrifuged at 200 g for 10 min and the pellet was stored at quantitated separately by hemacytometry. The ratio of the attached to floating -70°C. Cell protein was determined by the method of Bradford (33) on cells multiplied by 100 represents the 'apoptotic ratio. ' specimens which were solubilized with 0.1 N NaOH for 1 h at 37°C and As has been described by others (31,32) we were interested in determining sonicated for 10 s. Bovine serum albumin was utilized as the standard. The the cells that were in the terminal phases of apoptosis or necrotic in attached media samples were thawed and aliquots used for PGE 2 measurements without and floating cell populations in the presence and absence of a COX-2 inhibitor. extraction using RIA kits obtained from New England Nuclear (Dupont, Gall bladder cells (1ϫ10 5 ) were plated as described previously and maintained Boston, MA) as described previously (11) . Prostanoid concentrations were for 72 h with and without serum. Experiments were also performed in which determined in duplicate/mg cell protein. serum-supplemented cells were evaluated with and without SC 58125 (2.0, Statistical analysis was performed using a STAT II statistical program to 10 and 50 µM). Six wells per variable were evaluated and the percentage of perform analysis of variance. If the F-value was significant, differences attached and floating cells not excluding tryphan blue was determined between mean values were evaluated by employing Fischer's least significant evaluating 100 cells/well.
difference. As used throughout the text, 'significant' indicates P Ͻ 0.05. In addition it was intended to evaluate apoptosis in attached and floating cells by DNA agarose gel electrophoresis. Gall bladder cancer cells were Cincinnati, OH). Following centrifugation the top layer was transferred to another tube and absolute ethanol added. Following centrifugation, the inhibitor, VSA, had no effect on serum-stimulated or serum- at 72 h (Figure 2 ). We interpret this to indicate that COX-2 induces more cells to be apoptotic (Table III) and that there was no evidence that the apoptotic cells had more extensive and growth factor-stimulated mitogenesis. Incorporation of DNA degradation produced by the COX-2 inhibitor.
[ 3 H]thymidine by gall bladder cancer cells was significantly
Addition of serum to cell culture media decreased the inhibited by the COX-2 inhibitor in the presence of serum and number of floating versus attached cells (Table III) . When the in the cells stimulated by serum and growth factors (Table I) . cells were evaluated with regard to the ability of the cells to Antibodies generated against the thymidine analog BrdU exclude tryphan blue, more cells maintained in a serumcan produce an immunochemical method of detecting DNA free environment did not exclude tryphan blue (Table IV) . synthesis (27) . We employed BrdU detection by antibody Approximately 96% of the cells maintained in a serumtechniques as an alternative method to evaluate mitogenesis supplemented environment that were floating appeared to still in gall bladder cancer cells. The results presented in Table II be viable, as evaluated by their ability to exclude tryphan blue, confirm the results obtained with [ 3 H]thymidine incorporation. and presumed to be in various stages of apoptosis. This Serum, HGF and TGFα stimulated BrdU incorporation. The percentage was significantly decreased by the COX-2 inhibitor COX-1 inhibitor VSA did not alter the response, whereas the (Table IV) . COX-2 inhibitor significantly decreased mitogenesis stimulated
The mitogens increased DNA replication as evaluated by by serum and by growth factors as evaluated by BrdU [ 3 H]thymidine incorporation and BrdU labeling. Serum and incorporation (Table II) .
growth factors also decreased apoptosis. We intended to Cell growth may also be affected by rates of apoptosis or determine if these changes were associated with alterations in programmed cell death. We were interested in determining if COX enzyme levels. As seen in Figure 3 , COX-1 enzyme COX inhibitors altered apoptosis. Estimating the number of expression was detectable in cells maintained in serum-free apoptotic cells was performed by equating them to unattached media and there was apparent increased expression following cells (28) (29) (30) . Cells grown in serum-free media for 96 h had exposure to serum or serum and growth factors. COX-2 high rates of unattached cells with a significantly greater enzyme was also present in gall bladder cancer cells maintained apoptotic ratio than cells incubated in a serum-supplemented in serum-free and serum-supplemented media and there was media or a serum-supplemented media containing TGFα. In a apparent induction of COX-2 protein formation by serum and dose-related manner the COX-2 inhibitor, SC 58125, significgrowth factor stimulation particularly in response to TGFα. antly increased the apoptotic ratio when compared with values PGE 2 formation by serum-starved human gall bladder cancer produced by the cells maintained in serum-supplemented media cells was low and was significantly increased by exposure to and media containing serum and TGFα without the COX-2 10% FBS (Table V) . Neither growth factor significantly inhibitor (Table III) . Experiments evaluating the effects of increased PGE 2 formation compared with values produced by HGF and the COX-1 inhibitor, VSA, on the apoptotic ratio serum alone. VSA, the COX-1 inhibitor, had no effect on were not performed. PGE 2 levels while the COX-2 inhibitor, SC 58125, significantly When DNA degradation was evaluated in attached and decreased PGE 2 levels produced in the presence of serum and floating cells between 0 and 72 h, attached cells manifested serum ϩ growth factors. very little evidence of DNA laddering in cells maintained in a serum-free or serum-supplemented environment ( Figure  Discussion  1) . Floating cells maintained in serum-free culture media subjectively manifested more DNA degradation than did float-
The results of this study suggest that gall bladder cancer cell growth can be stimulated by mitogens, and that mitogens can ing cells maintained in a serum-supplemented environment. When gall bladder cancer cells maintained in a serumdecrease apoptosis. Serum and mitogens stimulated COX protein induction. The mitogenic stimulus can be decreased supplemented environment were exposed to the COX-2 inhibitor there was no evident increase in DNA degradation in by a specific COX-2 inhibitor, and the COX-2 inhibitor can increase apoptosis. The decreased mitogenesis and increased attached cells. While DNA degradation was extensive in the cells treated with the COX-2 inhibitor, there did not appear to apoptosis produced by the COX-2 inhibitor were associated with decreased PGE 2 formation. be evidence of more DNA degradation in the cells treated colon cancer cell line could be inhibited by the COX-2 enzyme inhibitor. Others have subsequently demonstrated that, in a variety of epithelial cell lines, specific COX-2 inhibitors The results of this study follow a typical pattern of response decrease mitogenesis (39, 40) . associated with the effect of COX-2 inhibitors on cell growth A significant amount of evidence derived from clinical in a number of epithelial cell lines. In a recent study we epidemiologic studies and in vitro studies employing nonevaluated a murine colon cancer cell line and found that specific NSAIDs suggested that non-specific COX inhibitors COX-1 enzyme was induced by serum exposure compared may prevent colon cancer (41) . Both in vitro and in vivo with cells maintained in a serum-free medium (34) . COX-2 studies evaluating the effect of non-specific NSAIDs on colon was not present in cells maintained in serum-free medium but cancer suggested that an important effect of NSAIDs on was induced by exposure to serum. Despite these differences in enzyme level, when compared with gall bladder cancer colon tumor cells was the induction of apoptosis (42) . In colon present study, COX-1 inhibitors do not alter mitogenesis in gall bladder cancer cells stimulated by serum or growth factors. The mechanism by which COX-2 enzyme inhibition alters mitogenesis in gall bladder cancer cells is unknown. It would seem most likely that the response is due to decreased prostanoid formation and in the present study decreased PGE 2 concentrations correlated with decreased mitogenesis and increased apoptosis.
There was, however, no evident increase in PGE 2 production associated with stimulation of mitogenesis produced by serum or growth factors. We know of no other information related to the effects of prostanoids on the growth patterns of gall bladder mucosal cells and the effect of various prostanoids on mitogenesis and apoptosis in gall bladder cancer will require further study. In other types of intestinal epithelial cells the information is confusing. Previous studies demonstrated that PGE 2 stimulated the growth of cells derived from human colon cancer (13) which would correlate well with the inhibitory response of gall bladder cancer cell mitogenesis produced by the COX-2 inhibitor. Other studies failed to demonstrate an effect of PGE 2 on mitogenesis in colon cancer cell lines (46). compared with the specific COX-2 inhibitor, Santini et al. (31) a Value from the serum-treated cells was significantly different from the serum-free value.
concluded that COX-2 inhibition may not affect apoptosis by b COX inhibitor produced values significantly different from the values altering prostanoid metabolism. We found significant correlaproduced by the serum or serum and growth factor-treated cells.
tion between the effect of the COX-2 inhibitor on PGE 2 levels and its effect on apoptosis. It is possible that other prostanoids not measured could be mediating the response produced by cancer cell lines specific COX-2 inhibitors have also been shown to induce apoptosis (30,43).
Santini et al. (31) . The absence of a universal correlation between inhibition The above information has led to the speculation that the effect of NSAIDs on chemoprevention of epithelial cancers of proliferation and decreased prostanoid formation produced by COX-2 inhibitors and the inhibition of proliferation of may be due to the COX-2 activity of these agents, and that specific COX-2 inhibitors may have a role in preventing and cancer cells by PGE 2 has generated concern that the alterations in mitogenesis and apoptosis produced by COX-2 inhibition treating cancers originating in intestinal epithelium (17, 44, 45) . The results of the present study suggest that these same are not due to prostanoid changes (51). It has been postulated that COX-2 may independently be a tumor suppressor gene at relationships between COX-2 inhibition and suppression of gall bladder cancer growth in vitro exist and that specific 1q23-qter (51). The information presented in this study suggests that the COX-2 enzyme may play a role in the development COX-2 inhibitors may have a therapeutic role in preventing or treating gall bladder cancer. Based on information in the of gall bladder cancer. Further studies will be required to
